Title: An open label, 3-arm, randomised phase 2 study to compare the safety and efficacy of ponatinib in combination with either chemotherapy or blinatumomab
Funder
Amgen Ltd
Principal Investigator
Co-Investigators
Thomas, Ian
Project Details
Net value award figure for Cardiff University: £357,047.43
Start date: 01/01/2019
End date: 30/06/2024